Deutsche Securities Mauritius today offloaded 1.95 per cent stake in drug firm Jubilant Life Sciences for a little over Rs 122 crore through an open market transaction.
The shares were purchased by Citigroup Global Markets Mauritius Pvt Ltd.
According to information available with block data available with the stock exchange, Deutsche Securities sold a total of 3,103,408 shares or 1.95 per cent stake in Jubilant Life Sciences.
The scrip was sold at an average price of Rs 394.5, valuing the transaction at Rs 122.43 crore.
At the end of March quarter, Deutsche Securities held 1.95 per cent stake in the drug firm.
Shares of Jubilant Life Sciences closed at Rs 401.65 apiece on BSE, up 2.99 per cent from the previous close.
